Action Point Financial Planning’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-500
Closed -$2.34K – 2402
2026
Q2
$2.34K Buy
+500
New +$3.69K ﹤0.01% 2184

Other funds holding UNCY

Action Point Financial Planning's UNCY Position: Q3 2026 in Review

Action Point Financial Planning sold out of Unicycive Therapeutics (UNCY) in Q3 2026, closing a stake of 500 shares — an estimated $2.34K sold.

Action Point Financial Planning first reported a position in UNCY in Q2 2026 and held it in 1 quarter. The position peaked at $2.34K in Q2 2026. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Action Point Financial Planning reported no remaining Unicycive Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 500 Unicycive Therapeutics shares in Q3 2026, an estimated $2.34K.
  • Action Point Financial Planning first reported a position in Unicycive Therapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Unicycive Therapeutics position peaked at $2.34K in Q2 2026.
  • 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.